| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $321.8M | +8.6% |
| R&D Expense | $90.4M | +18.1% |
| SG&A Expense | $100.4M | +33.9% |
| Operating Income | -$77.2M | -159.8% |
| Pre-tax Income | -$76.2M | -137.6% |
| Income Tax | $379K | +126.6% |
| Net Income | -$76.6M | -149.9% |
| EPS (Basic) | -$1.44 | -144.1% |
| EPS (Diluted) | -$1.44 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.9M | -74.2% |
| Short-term Investments | $203.2M | — |
| Accounts Receivable | $66.3M | +11.0% |
| Inventory | $19.2M | +11.9% |
| Current Assets | $387.8M | -10.5% |
| Total Assets | $543.0M | -4.2% |
| Current Liabilities | $76.0M | -1.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.2M | -30.8% |
| Investing Cash Flow | -$228.5M | -578.9% |
| Financing Cash Flow | -$4.5M | -102.4% |
| -144.1% |
| Total Liabilities |
| $112.1M |
| +11.3% |
| Stockholders' Equity | $430.9M | -7.5% |